Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablation Versus Medical Management of Atrial Fibrillation in Heart Failure With Preserved Ejection fRaction and the Effects on Exercise Capacity (AMPERE)

NCT04282850 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT04282850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04282850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablation Versus Medical Management of Atrial Fibrillation in Heart Failure With Preserved Ejection fRaction and the Effects on Exercise Capacity (AMPERE)
Lead sponsor
Inova Health Care Services
Phase
Not applicable
Overall status
Terminated
Start date
July 10, 2023
Completion date
February 26, 2026
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, heart failure with normal ejection fraction